Latest Breaking News On - Konstantinosp koulogiannis - Page 1 : comparemela.com

PASCAL transcatheter valve repair system as good as MitraClip in patients with significant symptomatic DMR Not Eligible for Surgery: CLASP IID trial

According to a new randomized controlled trial PASCALtranscatheter valve repair system was non-inferior compared with MitraClip in patients with significant symptomatic DMR who are not eligible for.

United statesSouth koreaKonstantinosp koulogiannisEdwards lifesciencesValve centerMorristown medical centerBoston scientificUniversity of virginiaCardiovascular research foundationScott limAdvanced cardiac valve centerMorristown medicalHuman studyNovel transcatheter mitral valve repair systemJacc cardiovascular interventionsMitral regurgitation

Novel TEER Repair Device Meets Primary Endpoint in Treating Degenerative Mitral Regurgitation in Patients Not Eligible for Surgery

Results of the CLASP IID Trial Presented at TCT and published simultaneously in JACC: Cardiovascular Interventions

United statesKonstantinosp koulogiannisValve centerUniversity of virginiaMorristown medical centerCardiovascular research foundationScott limAdvanced cardiac valve centerMorristown medical

EDWARDS ANNOUNCES SIX-MONTH DATA CONFIRMING TEER AS SAFE AND EFFECTIVE FOR DMR IN FIRST HEAD-TO-HEAD TRIAL

BOSTON, Sept. 17, 2022 /PRNewswire/ Edwards Lifesciences Corporation announced results from CLASP IID, the first randomized controlled trial that directly compares two contemporary transcatheter. | September 17, 2022

United statesPhilippe genereuxFiras zahrKonstantinosp koulogiannisMegan coylewrightPaula grayburnJacobm mishellBernardj zovighianRaj makkarEdwards lifesciencesLindad gillamExchange commissionPrnewswire edwards lifesciences corporationSecurities exchangeEdwards lifesciences corporationCardiovascular research foundation

EDWARDS ANNOUNCES SIX-MONTH DATA CONFIRMING TEER AS SAFE AND EFFECTIVE FOR DMR IN FIRST HEAD-TO-HEAD TRIAL

EDWARDS ANNOUNCES SIX-MONTH DATA CONFIRMING TEER AS SAFE AND EFFECTIVE FOR DMR IN FIRST HEAD-TO-HEAD TRIAL
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesPhilippe genereuxFiras zahrKonstantinosp koulogiannisMegan coylewrightPaula grayburnJacobm mishellBernardj zovighianRaj makkarEdwards lifesciencesLindad gillamExchange commissionPrnewswire edwards lifesciences corporationSecurities exchangeEdwards lifesciences corporationCardiovascular research foundation

EDWARDS ANNOUNCES SIX-MONTH DATA CONFIRMING TEER AS SAFE AND EFFECTIVE FOR DMR IN FIRST HEAD-TO-HEAD TRIAL - Edwards Lifesciences (NYSE:EW) - Press Release

BOSTON, Sept. 17, 2022 /PRNewswire/ Edwards Lifesciences Corporation EW announced results from CLASP IID, the first randomized controlled trial tha

United statesPhilippe genereuxFiras zahrKonstantinosp koulogiannisMegan coylewrightPaula grayburnJacobm mishellBernardj zovighianRaj makkarEdwards lifesciencesLindad gillamExchange commissionSecurities exchangeEdwards lifesciences corporationCardiovascular research foundationTranscatheter cardiovascular therapeutics